Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The occurrence of post-stroke depression results from the effects of biological, psychological, and social factors, likely involving neurotransmitters, neuroendocrine effects, nerve anatomy, neurotrophic factors, neural regeneration, inflammatory reactions, and social psyche factors.
Synaptotagmin promotes neurotransmitter release, regulates the transfer of synaptic vesicle to synaptic active zones, and is a key factor in information transfer among neurons.
The Xingnao Jieyu capsule has been shown to effectively relieve neurologic impairments and lessen depression. It remains poorly understood whether this capsule can be used to treat post-stroke depression.
Thus, Prof. Yongmei Yan and team from Shaanxi University of Chinese Medicine found that the Xingnao Jieyu capsules upregulated synaptotagmin expression in the hippocampi of rats with post-stroke depression, and improved depression symptoms.
The therapeutic effects of Xingnao Jieyu capsules were similar to those of fluoxetine.
These results, published in Neural Regeneration Research (Vol. 8, No. 19, 2013), can provide scientific evidence and theoretical basis for pathogenesis and treatment of post-stroke depression.
Article: "The effects of Xingnao Jieyu capsules on post-stroke depression are similar to those of fluoxetine," by Yongmei Yan1, 2, Wentao Fan1, 2, Li Liu3, Ru Yang1, Wenjia Yang1 (1 Department of Encephalopathy, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China; 2 Encephalopathology Key Subject of Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine of the People's Republic of China, Xianyang 712000, Shaanxi Province, China; 3 Research Room of Traditional Chinese Medicine Internal Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China)
Neural Regen Res. 2013;8(19):1765-1772. Yan YM, Fan WT, Liu L, Yang R, Yang WJ. doi:10.3969/j.issn.1673-5374.2013.19.004
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Stroke category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Research, Neural Regeneration. "Treating post-stroke depression with Xingnao Jieyu capsules or fluoxetine." Medical News Today. MediLexicon, Intl., 16 Aug. 2013. Web.
9 Dec. 2013. <http://www.medicalnewstoday.com/releases/264832>
Research, N. (2013, August 16). "Treating post-stroke depression with Xingnao Jieyu capsules or fluoxetine." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/264832.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.